Does REMDESIVIR Cause Therapy cessation? 215 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 215 reports of Therapy cessation have been filed in association with REMDESIVIR (Veklury). This represents 2.1% of all adverse event reports for REMDESIVIR.
215
Reports of Therapy cessation with REMDESIVIR
2.1%
of all REMDESIVIR reports
13
Deaths
29
Hospitalizations
How Dangerous Is Therapy cessation From REMDESIVIR?
Of the 215 reports, 13 (6.0%) resulted in death, 29 (13.5%) required hospitalization, and 9 (4.2%) were considered life-threatening.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REMDESIVIR. However, 215 reports have been filed with the FAERS database.
What Other Side Effects Does REMDESIVIR Cause?
Off label use (1,092)
Alanine aminotransferase increased (1,047)
Death (808)
Aspartate aminotransferase increased (713)
Bradycardia (652)
Acute kidney injury (605)
Covid-19 (570)
Drug ineffective (497)
Liver function test increased (447)
Respiratory failure (394)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which REMDESIVIR Alternatives Have Lower Therapy cessation Risk?
REMDESIVIR vs REMERON
REMDESIVIR vs REMICADE
REMDESIVIR vs REMIFENTANIL
REMDESIVIR vs REMIMAZOLAM
REMDESIVIR vs REMODULIN